May 1st, 2021 – Radio-Canada

Portrait de médecin  :  Dr Houfar Sekhavat

January 27 , 2021 – The Hill Time

Research team struggles to find public funds for low-cost generic drug that could treat COVID-19

October 9, 2020 – Radio-Canada

16:39 | Une start-up de Dieppe développe un traitement contre la COVID

September 30, 2020 – The Star

Narrow focus on vaccines is a risk we can’t afford

September 22, 2020 – The McGill Tribune

Canadian Biotech start-up to begin Phase 3 COVID-19 oral treatment trials

September 11, 2020 – Radio-Canada

La course au financement de remèdes contre la COVID-19 tiraille des scientifiques

September 7, 2020 – Global News

Developing coronavirus treatments ‘extremely important,’ experts say

September 3, 2020 – Radio-Canada

Un médicament contre la COVID-19 en cours d’élaboration à Dieppe

September 3, 2020 – TVA Nouvelles

Un autre médicament contre la COVID-19 testé au Québec

September 3, 2020 – La Presse

Un médicament générique contre la COVID-19 testé à Montréal

September 3, 2020 – Radio-Canada

Interview with Dr Jean Bourbeau (in French)

September 3, 2020 – Journal de Montréal

Un autre médicament contre la COVID-19 testé au Québec

September 3, 2020 – Complex

Canadian Drug Approved for Trials as COVID-19 Treatment Could Be Available This Year

September 3, 2020 – Narcity

A Canadian COVID-19 Treatment Just Got Phase 3 Trial Approval From The Government (VIDEO)

September 3, 2020 – Medical News

Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations

September 2, 2020 – 98.5 Montreal

Dr Jean Bourbeau radio interview on 98.5 Montreal with Paul Arcand (in French)

September 2, 2020 – News release

Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19

September 2, 2020 – News release

New COVID-19 Drug Therapy Developed by Canadian Biotech Start-up Headed for Phase III Clinical Trial Sponsored by the RI-MUHC

Looking to Invest?

Interested in investing or participating in the Clinical Trial?

Please complete the form below or email us at

    Clinical trialPotential investorBusiness (supplier, distributor, etc)Other

    Pulmonem Inc.
    855, Dieppe Blvd
    Dieppe, NB  E1A 7R8

    Media Enquiries
    Keelan Green